But there IS a lot of hype floating around this stack, and most of it comes from people who dont understand the underlying pharmacology or how to properly dose and cycle either compound
Cost depends on which GLP-1 medication fits you and your dose, and we'd rather give you a real number than a teaser rate so we go over exact pricing, in plain terms, at your consultation
Demographic and clinicopathologic characteristics were abstracted from medical records
Among 169,649 patients with MASLD, GLP-1 receptor agonist initiation was linked to significantly lower probability of incident cirrhosis [adjusted hazard ratio (aHR): 0.86, 95%CI: 0.80-0.93], hepatic decompensation (aHR: 0.77, 95%CI: 0.65-0.90), and hepatocellular carcinoma (HCC) (aHR: 0.79, 95%CI: 0.68-0.92) over a median follow-up of 3.5 years compared to non-users
The weekly monitoring can catch problems early before they become reasons to discontinue treatment